Insider Stock Trading History of Hansen John David


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hansen John David since year 2005. The trader's CIK number is 1186123. At the time of this reporting, Hansen John David is the PRESIDENT AND CEO of Mabvax Therapeutics Holdings, Inc. . (stock ticker symbol MBVX). See this page for all insider trading activities at Mabvax Therapeutics Holdings, Inc. .


Stock purchases, sales, and option exercises reported by insider Hansen John David since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-16 MBVX Mabvax Therapeutics Holdings, Inc. Sale 59,263 .92 54,521
2018-01-08 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 727,210 .00 0
2018-01-10 MBVX Mabvax Therapeutics Holdings, Inc. Sale 110,093 .96 105,689
2018-01-11 MBVX Mabvax Therapeutics Holdings, Inc. Sale 64,015 .98 62,734
2018-01-12 MBVX Mabvax Therapeutics Holdings, Inc. Sale 18,582 .96 17,838
2017-05-19 MBVX Mabvax Therapeutics Holdings, Inc. Buy 9,128 .88 7,987
2017-04-12 MBVX Mabvax Therapeutics Holdings, Inc. Sale 10,216 2.00 20,432
2017-04-07 MBVX Mabvax Therapeutics Holdings, Inc. Sale 666 2.00 1,335
2017-04-10 MBVX Mabvax Therapeutics Holdings, Inc. Sale 560 2.00 1,120
2017-04-11 MBVX Mabvax Therapeutics Holdings, Inc. Sale 250 2.00 500
2017-04-04 MBVX Mabvax Therapeutics Holdings, Inc. Sale 1,100 2.25 2,475
2017-04-05 MBVX Mabvax Therapeutics Holdings, Inc. Sale 2,450 2.15 5,269
2017-04-06 MBVX Mabvax Therapeutics Holdings, Inc. Sale 1,501 2.15 3,224
2017-04-02 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 40,687 .00 0
2016-08-17 MBVX Mabvax Therapeutics Holdings, Inc. Buy 3,119 .00 0
2016-04-04 MBVX Mabvax Therapeutics Holdings, Inc. Option Ex 301,084 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hansen John David (PRESIDENT AND CEO of Mabvax Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.